Intraday BUY SELL Signals
Intraday BUY SELL Signals
Interact to see
Advertisement
Advertisement
CURE vs SPXL
CURE vs SPXL Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
CURE vs. SPXL commentary
Dec 14, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CURE is a Hold and SPXL is a Buy.
SUMMARIES
FUNDAMENTALS
Fundamentals
SPXL has more net assets: 5.93B vs. CURE (181M). SPXL has a higher annual dividend yield than CURE: SPXL (36.000) vs CURE (18.882). CURE was incepted earlier than SPXL: CURE (15 years) vs SPXL (17 years). SPXL (0.87) has a lower expense ratio than CURE (0.93). SPXL has a higher turnover CURE (23.00) vs CURE (23.00).
| CURE | SPXL | CURE / SPXL | |
| Gain YTD | 18.882 | 36.000 | 52% |
| Net Assets | 181M | 5.93B | 3% |
| Total Expense Ratio | 0.93 | 0.87 | 107% |
| Turnover | 23.00 | 29.00 | 79% |
| Yield | 0.91 | 0.75 | 122% |
| Fund Existence | 15 years | 17 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| CURE | SPXL | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 88% | 3 days ago 85% |
| Stochastic ODDS (%) | 3 days ago 90% | 3 days ago 89% |
| Momentum ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| MACD ODDS (%) | 3 days ago 86% | 3 days ago 90% |
| TrendWeek ODDS (%) | 3 days ago 89% | 3 days ago 90% |
| TrendMonth ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| Advances ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| Declines ODDS (%) | 5 days ago 90% | 5 days ago 88% |
| BollingerBands ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| Aroon ODDS (%) | 3 days ago 90% | 3 days ago 84% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NRMGX | 18.93 | 0.17 | +0.91% |
| Neuberger Berman Mid Cap Growth R6 | |||
| VSMIX | 31.51 | 0.24 | +0.77% |
| Invesco Small Cap Value Y | |||
| MYITX | 10.44 | 0.07 | +0.68% |
| NYLI WMC International Research Eq Cl A | |||
| PXWEX | 37.60 | 0.13 | +0.35% |
| Impax Ellevate Global Women's Ldr Inv | |||
| APLIX | 13.60 | N/A | N/A |
| Cavanal Hill Hedged Equity Income Inv | |||
CURE and
Correlation & Price change
A.I.dvisor indicates that over the last year, CURE has been closely correlated with TMO. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CURE jumps, then TMO could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To CURE | 1D Price Change % | ||
|---|---|---|---|---|
| CURE | 100% | +2.77% | ||
| TMO - CURE | 72% Closely correlated | +0.89% | ||
| IQV - CURE | 71% Closely correlated | +1.37% | ||
| A - CURE | 68% Closely correlated | -0.42% | ||
| PFE - CURE | 68% Closely correlated | +0.08% | ||
| MTD - CURE | 67% Closely correlated | +1.12% | ||
More | ||||
SPXL and
Correlation & Price change
A.I.dvisor indicates that over the last year, SPXL has been loosely correlated with MSFT. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPXL jumps, then MSFT could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To SPXL | 1D Price Change % | ||
|---|---|---|---|---|
| SPXL | 100% | +0.70% | ||
| MSFT - SPXL | 63% Loosely correlated | +1.03% | ||
| AAPL - SPXL | 62% Loosely correlated | -0.27% | ||
| AMZN - SPXL | 60% Loosely correlated | -0.65% | ||
| META - SPXL | 59% Loosely correlated | +0.40% | ||
| NVDA - SPXL | 56% Loosely correlated | -1.55% | ||
More | ||||